Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

John Allendorf

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5001230699. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: none · 2014: 3 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 11

  1. Neoadjuvant Therapy-Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis. Co-author DOI 10.1111/cas.70320↗
  2. Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer Database. Co-author DOI 10.1002/wjs.12431↗
  3. Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. Co-author DOI 10.1038/s41698-025-00848-2↗
  4. Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable p… Co-author DOI 10.1002/cncr.29112↗
  5. Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer. Last author DOI 10.1007/s00268-013-2384-z↗
  6. Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma. Last author DOI 10.1007/s11605-014-2529-x↗
  7. Routine intraoperative hepatic sonography does not affect staging or postsurgical hepatic recurrence in pancreatic adenocarcinoma. Co-author DOI 10.7863/ultra.33.1.47↗
  8. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. Last author DOI 10.1007/s11605-011-1754-9↗
  9. An update on surgical staging of patients with pancreatic cancer. First author DOI 10.6092/1590-8577/692↗
  10. Management of borderline resectable pancreatic adenocarcinoma. Co-author DOI 10.6092/1590-8577/695↗
  11. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Co-author PMID 21737893↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Shusterman · 2 shared papers, 2025–2026 · strength 0.45
  2. Jessica L. Widmer · 2 shared papers, 2025–2026 · strength 0.45
  3. Megan D. Winner · 5 shared papers, 2012–2025 · strength 0.39
  4. Yao‐Zhong Liu · 1 shared paper, 2026 · strength 0.24
  5. Xiaofei Zhang · 1 shared paper, 2026 · strength 0.24
  6. Anthony M Sorrentino · 1 shared paper, 2025 · strength 0.22
  7. Sarah R. Kaslow · 1 shared paper, 2025 · strength 0.22
  8. Mahip Grewal · 1 shared paper, 2025 · strength 0.22
  9. Christopher L. Wolfgang · 1 shared paper, 2025 · strength 0.22
  10. Diane M. Simeone · 1 shared paper, 2025 · strength 0.22
  11. Greg D. Sacks · 1 shared paper, 2025 · strength 0.22
  12. Ammar A. Javed · 1 shared paper, 2025 · strength 0.22
  13. Danting Li · 1 shared paper, 2025 · strength 0.21
  14. Venu Gopal Pillarisetty · 1 shared paper, 2025 · strength 0.21
  15. Xiaofei Zhang · 1 shared paper, 2025 · strength 0.21
  16. Yaozhong Liu · 1 shared paper, 2025 · strength 0.21
  17. John A. Chabot · 4 shared papers, 2014–2015 · strength 0.19
  18. Muhammad Wasif Saif · 3 shared papers, 2011–2012 · strength 0.13
  19. Irene Epelboym · 2 shared papers, 2014 · strength 0.10
  20. Beth Schrope · 2 shared papers, 2014–2015 · strength 0.09
  21. Joseph DiNorcia · 2 shared papers, 2012–2014 · strength 0.07
  22. Isadora C. Botwinick · 1 shared paper, 2014 · strength 0.05
  23. Leonora W. Mui · 1 shared paper, 2014 · strength 0.05
  24. Peter M. Einersen · 1 shared paper, 2014 · strength 0.05
  25. Jeffrey H. Newhouse · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.